ECE 2021

Cushing-Syndrom - aktuelle Therapielandschaft

Neue Entwicklungen bei AGS-Therapie

Hypoparathyreodismus neu bewertet

Sequenztherapie der Osteoporose

Endokrine Disruptoren

Cardiovascular events in adult patients with chronic hypoparathyroidism treated with rhPTH(1–84) compared with a historical control cohort

Non-nuclear cataracts in hypoparathyroidism are associated with biochemical control of the disease

Bisphosphonates after Denosumab withdrawal reduce the vertebral fractures incidence

Challenges of hypoparathyroidism

Quantifying the real-world clinical and economic burden of chronic hypoparathyroidism on secondary care in England: A multi-arm, retrospective cohort study

AAV liver gene therapy-mediated inhibition of FGF23 signaling as a therapeutic strategy for X-linked hypophosphatemia

Bone consequences of high dose denosumab to treat an aneurysmal bone cyst, an example of the European Reference Network support

TransCon PTH as a potential hormone replacement therapy for

patients with hypoparathyroidism: PaTH forward open-label

extension trial week 26 results

Safety, tolerability and pharmacodynamics of AZP-3601, a novel long-acting PTH analog, in healthy adults: Data from a randomized, double-blind, placebo-controlled phase 1 study

Risk of chronic kidney disease and change in GFR in adult patients with chronic hypoparathyroidism treated with rhPTH(1–84) compared with a historical control cohort

The effect of intra-operative autofluorescence monitoring on unintentional parathyroid gland excision rates and post-operative PTH concentrations

One year in bone

News about hypophosphatasia

Deficiency or insufficiency of vitamin D and the frequency of hypocalcemia episodes and the circadian rhythm of serum calcium level

Fascin-1, a novel-circulating marker for the prognosis of the metastatic adrenocortical carcinoma

Pre-operative hypercortisolism and post-operative adrenal insufficiency in pheochromocytomas: a single center retrospective analysis of 168 patients

Primary results from MATCH: A randomised controlled trial in primary aldosteronism

Salivary steroid and 11‑oxygenated androgen profiles in patients with congenital adrenal hyperplasia on various glucocorticoid replacement regimens

Neuroendocrine stress response at single cell resolution

Adverse events of mitotane treatment in patients with adrenocortical carcinoma

Steroid metabolomics for the detection of malignancy in adrenal tumours

Tildacerfont for the treatment of patients with classic congenital adrenal hyperplasia: results from a 12-week phase 2 clinical trial in adults with classic CAH

Results of the ADIUVO trial, the first randomized study on post-operative adjuvant mitotane in patients with adrenocortical carcinoma

Novel treatment and monitoring options for CAH

Thymic neuroendocrine tumor and mortality in MEN 1 patients: the spanish registry

Reassessment of the diagnostic criteria of insulinoma: A retrospective monocentric cohort study of 72-h fasting trial in 124 patients

Can the follow-up imaging interval for non-functioning pituitary microadenomas be extended?

Osilodrostat, a potent oral 11β-hydroxylase inhibitor

Osilodrostat provides sustained control of urinary free cortisol in patients with Cushing’s disease: final results from a prospective, open-label study (LINC 2)

Addition of cabergoline to oral octreotide capsules may improve biochemical control in patients with acromegaly who are inadequately controlled with monotherapy

GH replacement in adults

Identification of a dose range for once daily oral paltusotine in patients with acromegaly that maintains IGF-1 levels when switching from long-acting somatostatin receptor ligand therapy

Metyrapone treatment in endogenous Cushing’s syndrome. Long term efficacy and safety results of the extension of the phase III/IV study PROMPT

A Phase 3 Large International Noninferiority Trial (MPOWERED): Assessing Maintenance of Response to Oral Octreotide Capsules in Comparison to Injectable Somatostatin Receptor Ligands

Effect of IL-1 receptor antagonism on hyperandrogenemia in women with polycystic ovary syndrome

Non-contraceptive therapeutic use of combined oral contraceptives in PCOS

Long-term effects of testosterone replacement therapy

Monogenic variants in the Finnish Pediatric Diabetes Register

Endocrine Disruptors - a key challenge for endocrinologists, authorities and our future

COVID-19 and hormones – the role of Endocrinologists in preventing and improving outcomes of COVID-19